Metraipolis › archive › dc_7473ee96119e

Hypersensitivity reactions to dengue vaccine TAK-003 (Qdenga®) following an immunization campaign targeting children and adolescents — Europe PMC PMID:42384997

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42384997
DOI
10.1590/0037-8682-0198-2026
License (as archived)
solo-consultazione
Archived
2026-10-18T16:17:07.564Z
SHA-256 of the archived text
e27d506f1c0a2b0c57af83fefa87eafd37e6ac4dab48af37fe25ee6070680343
Stable URL of this page
https://metraipolis.com/documento/dc_7473ee96119e

How to cite

Hypersensitivity reactions to dengue vaccine TAK-003 (Qdenga®) following an immunization campaign targeting children and adolescents — Europe PMC PMID:42384997 — Europe PMC (en), https://europepmc.org/article/MED/42384997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7473ee96119e (Metraipolis archive dc_7473ee96119e, sha256 e27d506f1c0a2b0c57af83fefa87eafd37e6ac4dab48af37fe25ee6070680343)
BibTeX
@misc{dc7473ee96119e,
  title = {Hypersensitivity reactions to dengue vaccine TAK-003 (Qdenga®) following an immunization campaign targeting children and adolescents — Europe PMC PMID:42384997},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42384997},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7473ee96119e; sha256 e27d506f1c0a2b0c57af83fefa87eafd37e6ac4dab48af37fe25ee6070680343},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42384997. Agents can read the archived copy with the MCP tool read_document.